鼻窦未分化癌的现代治疗方法和疗效:一项荟萃分析。

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Manuela Burggraf MD, Stefan Schiele PhD, Rubens Thölken MD, Francisco José Farfán López MD, Noran Elawany, Johannes Zenk PhD, Johannes Doescher PhD
{"title":"鼻窦未分化癌的现代治疗方法和疗效:一项荟萃分析。","authors":"Manuela Burggraf MD,&nbsp;Stefan Schiele PhD,&nbsp;Rubens Thölken MD,&nbsp;Francisco José Farfán López MD,&nbsp;Noran Elawany,&nbsp;Johannes Zenk PhD,&nbsp;Johannes Doescher PhD","doi":"10.1002/hed.27910","DOIUrl":null,"url":null,"abstract":"<p>Induction chemotherapy (IC) recently gained importance for treatment of sinonasal undifferentiated carcinoma (SNUC). We analyzed our SNUC cases and performed a meta-analysis with focus on survival-rates stratified by treatment. SNUC cases at our institution were retrospectively evaluated. A systematic literature review was conducted to analyze treatment and outcome of SNUC. To calculate 5-year and 2-year overall survival (OS), individual patient data (IPD) were analyzed using Kaplan–Meier estimators and Cox proportional hazard regression to identify associations between types of therapy and survival. A random effects model for pooled estimates of 5-year survival was applied to studies without IPD data. Five-year OS of our SNUC cases (<i>n</i> = 9) was 44.4%. The IPD analysis (<i>n</i> = 192) showed a significantly better 5-year OS for patients who received induction chemotherapy (72.6% vs. 44.5%). The pooled 5-year OS of 13 studies identified in the literature search was 43.8%. IC should be considered in every patient diagnosed with SNUC.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hed.27910","citationCount":"0","resultStr":"{\"title\":\"Contemporary treatment and outcome of sinonasal undifferentiated carcinoma: A meta-analysis\",\"authors\":\"Manuela Burggraf MD,&nbsp;Stefan Schiele PhD,&nbsp;Rubens Thölken MD,&nbsp;Francisco José Farfán López MD,&nbsp;Noran Elawany,&nbsp;Johannes Zenk PhD,&nbsp;Johannes Doescher PhD\",\"doi\":\"10.1002/hed.27910\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Induction chemotherapy (IC) recently gained importance for treatment of sinonasal undifferentiated carcinoma (SNUC). We analyzed our SNUC cases and performed a meta-analysis with focus on survival-rates stratified by treatment. SNUC cases at our institution were retrospectively evaluated. A systematic literature review was conducted to analyze treatment and outcome of SNUC. To calculate 5-year and 2-year overall survival (OS), individual patient data (IPD) were analyzed using Kaplan–Meier estimators and Cox proportional hazard regression to identify associations between types of therapy and survival. A random effects model for pooled estimates of 5-year survival was applied to studies without IPD data. Five-year OS of our SNUC cases (<i>n</i> = 9) was 44.4%. The IPD analysis (<i>n</i> = 192) showed a significantly better 5-year OS for patients who received induction chemotherapy (72.6% vs. 44.5%). The pooled 5-year OS of 13 studies identified in the literature search was 43.8%. IC should be considered in every patient diagnosed with SNUC.</p>\",\"PeriodicalId\":2,\"journal\":{\"name\":\"ACS Applied Bio Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-08-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hed.27910\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Bio Materials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/hed.27910\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/hed.27910","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

摘要

最近,诱导化疗(IC)在鼻窦鼻腔未分化癌(SNUC)的治疗中变得越来越重要。我们分析了本院的鼻窦未分化癌病例,并进行了一项荟萃分析,重点关注按治疗方法分层的生存率。我们对本机构的鼻窦未分化癌病例进行了回顾性评估。我们进行了系统的文献回顾,分析了SNUC的治疗和结果。为了计算5年和2年总生存率(OS),我们使用卡普兰-梅耶估计器和Cox比例危险回归分析了单个患者数据(IPD),以确定治疗类型与生存率之间的关联。对于没有IPD数据的研究,则采用随机效应模型对5年生存率进行汇总估计。我们的SNUC病例(n = 9)的5年OS为44.4%。IPD分析(n = 192)显示,接受诱导化疗的患者的5年生存率明显更高(72.6%对44.5%)。文献检索中发现的13项研究的5年生存率合计为43.8%。每一位确诊为SNUC的患者都应考虑接受IC治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Contemporary treatment and outcome of sinonasal undifferentiated carcinoma: A meta-analysis

Contemporary treatment and outcome of sinonasal undifferentiated carcinoma: A meta-analysis

Induction chemotherapy (IC) recently gained importance for treatment of sinonasal undifferentiated carcinoma (SNUC). We analyzed our SNUC cases and performed a meta-analysis with focus on survival-rates stratified by treatment. SNUC cases at our institution were retrospectively evaluated. A systematic literature review was conducted to analyze treatment and outcome of SNUC. To calculate 5-year and 2-year overall survival (OS), individual patient data (IPD) were analyzed using Kaplan–Meier estimators and Cox proportional hazard regression to identify associations between types of therapy and survival. A random effects model for pooled estimates of 5-year survival was applied to studies without IPD data. Five-year OS of our SNUC cases (n = 9) was 44.4%. The IPD analysis (n = 192) showed a significantly better 5-year OS for patients who received induction chemotherapy (72.6% vs. 44.5%). The pooled 5-year OS of 13 studies identified in the literature search was 43.8%. IC should be considered in every patient diagnosed with SNUC.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信